Results of a 950-patient phase 2/3 clinical characterization-association study to classify patients with potentially malignant oral disorders (Pmods) using a non-invasive lab-on- a-chip (LOC) approach

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S70-70
JournalOral Oncology
Volume49
DOIs
StatePublished - 2013

Cite this